Vontobel Holding Ltd. Ginkgo Bioworks Holdings, Inc. Transaction History

Vontobel Holding Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jun 03, 2024	BUY	$1.61 - $2.54 $35,420 - $55,880	22,000 Added 95.65%	45,000 $81,000
Q3 2023 Oct 10, 2023	BUY	$1.61 - $2.54 $35,420 - $55,880	22,000 Added 95.65%	45,000 $81,000
Q2 2023 Jun 03, 2024	BUY	$1.14 - $1.95 $5,699 - $9,750	5,000 Added 27.78%	23,000 $42,000
Q2 2023 Jul 24, 2023	BUY	$1.14 - $1.95 $5,699 - $9,750	5,000 Added 27.78%	23,000 $42,000
Q1 2023 Jun 03, 2024	BUY	$1.2 - $2.19 $21,600 - $39,420	18,000 New	18,000 $23,000
Q1 2023 Apr 12, 2023	BUY	$1.2 - $2.19 $6,000 - $10,950	5,000 Added 38.46%	18,000 $23,000
Q4 2022 Feb 14, 2023	BUY	$1.63 - $3.52 $21,190 - $45,760	13,000 New	13,000 $21,000
Q2 2022 Jul 27, 2022	SELL	$2.2 - $4.2 $57,490 - $109,754	-26,132 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.83 - $8.69 $73,953 - $227,087	26,132 New	26,132 $105,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.